公司资料
Fulgent Genetics, Inc. 股价、新闻与催化剂
- 股票代码:
- FLGT
- 交易所:
- NASDAQ
- 行业:
- MedTech
- 所在地:
- United States
股票表现
18.66 USD (+0.54%)
收盘价
最后更新: 2026年8月17日
531M USD
市值
股价为何变动
As of Aug 17, 2026, FLGT closed up 0.54% at $18.66. No new same-company headline was identified in the current news window.
公司概览
Precision Medicine Business
Fulgent Genetics operates a laboratory-services business alongside a therapeutic-development portfolio. The company aims to combine diagnostic capabilities with drug development to become an integrated precision-medicine organization.
Laboratory Services
Fulgent provides technical laboratory testing and physician interpretation services. Its operations include genetic and specialty diagnostic capabilities serving healthcare providers, institutions and other customers.
Oncology Therapeutics
The therapeutic business uses nanoencapsulation and targeted-delivery technology to improve the pharmacokinetics and therapeutic window of cancer drugs. Clinical candidates FID-007 and FID-022 represent the lead applications of this platform.
未来催化剂
- Phase 2 FID-007 data in a rapid oral presentation at the 2026 ASCO Annual Meeting.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。